114 related articles for article (PubMed ID: 7526208)
1. Very efficient myoblast allotransplantation in mice under FK506 immunosuppression.
Kinoshita I; Vilquin JT; Guérette B; Asselin I; Roy R; Tremblay JP
Muscle Nerve; 1994 Dec; 17(12):1407-15. PubMed ID: 7526208
[TBL] [Abstract][Full Text] [Related]
2. Utilization of myoblasts from transgenic mice to evaluate the efficacy of myoblast transplantation.
Kinoshita I; Huard J; Tremblay JP
Muscle Nerve; 1994 Sep; 17(9):975-80. PubMed ID: 8065399
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment of myoblast cultures with basic fibroblast growth factor increases the efficacy of their transplantation in mdx mice.
Kinoshita I; Vilquin JT; Tremblay JP
Muscle Nerve; 1995 Aug; 18(8):834-41. PubMed ID: 7630343
[TBL] [Abstract][Full Text] [Related]
4. Intramuscular migration of myoblasts transplanted after muscle pretreatment with metalloproteinases.
Torrente Y; El Fahime E; Caron NJ; Bresolin N; Tremblay JP
Cell Transplant; 2000; 9(4):539-49. PubMed ID: 11038070
[TBL] [Abstract][Full Text] [Related]
5. Lymphocyte infiltration following allo- and xenomyoblast transplantation in mdx mice.
Guérette B; Asselin I; Vilquin JT; Roy R; Tremblay JP
Muscle Nerve; 1995 Jan; 18(1):39-51. PubMed ID: 7799997
[TBL] [Abstract][Full Text] [Related]
6. Prevention by anti-LFA-1 of acute myoblast death following transplantation.
Guérette B; Skuk D; Célestin F; Huard C; Tardif F; Asselin I; Roy B; Goulet M; Roy R; Entman M; Tremblay JP
J Immunol; 1997 Sep; 159(5):2522-31. PubMed ID: 9278346
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppression with FK 506 insures good success of myoblast transplantation in MDX mice.
Kinoshita I; Vilquin JT; Guérette B; Asselin I; Roy R; Lille S; Tremblay JP
Transplant Proc; 1994 Dec; 26(6):3518. PubMed ID: 7527978
[No Abstract] [Full Text] [Related]
8. Myoblast transplantation in non-dystrophic dog.
Ito H; Vilquin JT; Skuk D; Roy B; Goulet M; Lille S; Dugré FJ; Asselin I; Roy R; Fardeau M; Tremblay JP
Neuromuscul Disord; 1998 Apr; 8(2):95-110. PubMed ID: 9608563
[TBL] [Abstract][Full Text] [Related]
9. Increased granzyme B mRNA after alloincompatible myoblast transplantation.
Guérette B; Roy R; Tremblay M; Asselin I; Kinoshita I; Puymirat J; Tremblay JP
Transplantation; 1995 Nov; 60(9):1011-6. PubMed ID: 7491674
[TBL] [Abstract][Full Text] [Related]
10. Successful myoblast transplantation in primates depends on appropriate cell delivery and induction of regeneration in the host muscle.
Skuk D; Roy B; Goulet M; Tremblay JP
Exp Neurol; 1999 Jan; 155(1):22-30. PubMed ID: 9918701
[TBL] [Abstract][Full Text] [Related]
11. Transient immunosuppression by FK506 permits a sustained high-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscles of adult dystrophic (mdx) mice.
Lochmüller H; Petrof BJ; Pari G; Larochelle N; Dodelet V; Wang Q; Allen C; Prescott S; Massie B; Nalbantoglu J; Karpati G
Gene Ther; 1996 Aug; 3(8):706-16. PubMed ID: 8854096
[TBL] [Abstract][Full Text] [Related]
12. Progress in myoblast transplantation: a potential treatment of dystrophies.
Skuk D; Tremblay JP
Microsc Res Tech; 2000 Feb 1-15; 48(3-4):213-22. PubMed ID: 10679968
[TBL] [Abstract][Full Text] [Related]
13. High efficiency of muscle regeneration after human myoblast clone transplantation in SCID mice.
Huard J; Verreault S; Roy R; Tremblay M; Tremblay JP
J Clin Invest; 1994 Feb; 93(2):586-99. PubMed ID: 8113396
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppression by FK506 markedly prolongs expression of adenovirus-delivered transgene in skeletal muscles of adult dystrophic [mdx] mice.
Lochmüller H; Petrof BJ; Allen C; Prescott S; Massie B; Karpati G
Biochem Biophys Res Commun; 1995 Aug; 213(2):569-74. PubMed ID: 7544122
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of increasing dystrophin-positive myofibers by myoblast transplantation: study using mdx/beta-galactosidase transgenic mice.
Kinoshita I; Vilquin JT; Tremblay JP
Acta Neuropathol; 1996; 91(5):489-93. PubMed ID: 8740229
[TBL] [Abstract][Full Text] [Related]
16. Human myoblast transplantation in immunodeficient and immunosuppressed mice: evidence of rejection.
Huard J; Roy R; Guérette B; Verreault S; Tremblay G; Tremblay JP
Muscle Nerve; 1994 Feb; 17(2):224-34. PubMed ID: 8114793
[TBL] [Abstract][Full Text] [Related]
17. Quantification of normal dystrophin mRNA following myoblast transplantation in mdx mice.
Asselin I; Tremblay M; Vilquin JT; Guérette B; Roy R; Tremblay JP
Muscle Nerve; 1995 Sep; 18(9):980-6. PubMed ID: 7643878
[TBL] [Abstract][Full Text] [Related]
18. Ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic muscles.
Floyd SS; Clemens PR; Ontell MR; Kochanek S; Day CS; Yang J; Hauschka SD; Balkir L; Morgan J; Moreland MS; Feero GW; Epperly M; Huard J
Gene Ther; 1998 Jan; 5(1):19-30. PubMed ID: 9536261
[TBL] [Abstract][Full Text] [Related]
19. Expression of human dystrophin following the transplantation of genetically modified mdx myoblasts.
Moisset PA; Gagnon Y; Karpati G; Tremblay JP
Gene Ther; 1998 Oct; 5(10):1340-6. PubMed ID: 9930339
[TBL] [Abstract][Full Text] [Related]
20. Exercise improves the success of myoblast transplantation in mdx mice.
Bouchentouf M; Benabdallah BF; Mills P; Tremblay JP
Neuromuscul Disord; 2006 Aug; 16(8):518-29. PubMed ID: 16919954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
